Invention Grant
- Patent Title: Substituted heterocyclic compounds
- Patent Title (中): 取代的杂环化合物
-
Application No.: US12702825Application Date: 2010-02-09
-
Publication No.: US08716319B2Publication Date: 2014-05-06
- Inventor: Matthew Abelman , Robert Jiang , Jeff Zablocki
- Applicant: Matthew Abelman , Robert Jiang , Jeff Zablocki
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent Francis O. Ginah; J. Elin Hartrum
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A61K31/44 ; C07D213/803
Abstract:
The present invention relates to novel heterocyclic compounds and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula (I): wherein Q1, Q2, R2, R3, R4, R5, and R6 are as described herein. The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds.
Public/Granted literature
- US20100197684A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS Public/Granted day:2010-08-05
Information query
IPC分类:
